Thorney Opportunities Ltd (TOP.AX) stock: key figures, P/E, revenue and dividend
Financials · Investment Banking & Brokerage · Australia · ISIN AU000000TOP2
Price
0.54 AUD
Market cap
91.79 m AUD
P/E (2026)
107.04
P/S (2026)
–
Dividend yield
5.14 %
Net margin
-110.56 %
Return on equity (ROE)
0.57 %
Return on assets (ROA)
0.52 %
Thorney Opportunities Ltd financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 17.52 m AUD | -775,611.00 AUD |
| Gross profit | 17.52 m AUD | -3.89 m AUD |
| Operating income | 14.11 m AUD | -4.44 m AUD |
| EBIT | 28.22 m AUD | – |
| Net income | 8.54 m AUD | 857,511.00 AUD |
| Diluted EPS – continuing operations | 0.05 AUD | 0.00 AUD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Thorney Opportunities Ltd
Thorney Opportunities Ltd is an equity fund launched and managed by Thorney Management Services Pty Ltd. The fund invests in the public equity markets of Australia. It seeks to invest in stocks of companies operating across diversified sectors. Thorney Opportunities Ltd is domiciled in Australia.
More stocks
- ALTISOURCE PORTFOLIO SOLUTIONS S.A. (ASPS)
- Sekar Laut Tbk (SKLT.JK)
- 3D Global Biotech Inc. (6808.TWO)
- Pungguk Ethanol Industrial Co. Ltd (023900.KQ)
- Sheng Yi Development Co.,Ltd (5455.TWO)
- SUI Group Holdings Ltd. (SUIG)
- BIG SKY INDUSTRIAL INC. (BSIN)
- Choong Ang Vaccine Laboratory Co. Ltd (072020.KQ)
- Hankook Cosmet (123690.KS)
- Afastor Corporation (6707.TWO)
- Acrivon Therapeutics, Inc. (ACRV)
- NETSOL TECHNOLOGIES INC (NTWK)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.